366 related articles for article (PubMed ID: 32733618)
1. A Circulating Long Noncoding RNA Panel Serves as a Diagnostic Marker for Hepatocellular Carcinoma.
Huang J; Zheng Y; Xiao X; Liu C; Lin J; Zheng S; Yang B; Ou Q
Dis Markers; 2020; 2020():5417598. PubMed ID: 32733618
[TBL] [Abstract][Full Text] [Related]
2. Serum long non-coding RNA SCARNA10 serves as a potential diagnostic biomarker for hepatocellular carcinoma.
Han Y; Jiang W; Wang Y; Zhao M; Li Y; Ren L
BMC Cancer; 2022 Apr; 22(1):431. PubMed ID: 35443674
[TBL] [Abstract][Full Text] [Related]
3. Circulating LncRNAs Serve as Diagnostic Markers for Hepatocellular Carcinoma.
Yuan W; Sun Y; Liu L; Zhou B; Wang S; Gu D
Cell Physiol Biochem; 2017; 44(1):125-132. PubMed ID: 29130980
[TBL] [Abstract][Full Text] [Related]
4. HULC and Linc00152 Act as Novel Biomarkers in Predicting Diagnosis of Hepatocellular Carcinoma.
Li J; Wang X; Tang J; Jiang R; Zhang W; Ji J; Sun B
Cell Physiol Biochem; 2015; 37(2):687-96. PubMed ID: 26356260
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Potential of the Serum lncRNAs HOTAIR, BRM and ICR for Hepatocellular Carcinoma.
Lou ZH; Xu KY; Qiao L; Su XQ; Ou-Yang Y; Miao LB; Liu F; Wang Y; Fu A; Ren XH; Huang JS; Li ZY; Bao JF
Front Biosci (Landmark Ed); 2022 Sep; 27(9):264. PubMed ID: 36224021
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA MyD88 functions as a promising diagnostic biomarker in hepatocellular carcinoma.
Wang Z; Gao P; Sun W; Rehman AU; Jiang J; Xu S; Xue C; Zhu C; Qin X
Front Endocrinol (Lausanne); 2023; 14():938102. PubMed ID: 36793272
[TBL] [Abstract][Full Text] [Related]
7. The long noncoding RNAs PVT1 and uc002mbe.2 in sera provide a new supplementary method for hepatocellular carcinoma diagnosis.
Yu J; Han J; Zhang J; Li G; Liu H; Cui X; Xu Y; Li T; Liu J; Wang C
Medicine (Baltimore); 2016 Aug; 95(31):e4436. PubMed ID: 27495068
[TBL] [Abstract][Full Text] [Related]
8. The expression of long non coding RNA genes is associated with expression with polymorphisms of HULC rs7763881 and MALAT1 rs619586 in hepatocellular carcinoma and HBV Egyptian patients.
Motawi TMK; El-Maraghy SA; Sabry D; Mehana NA
J Cell Biochem; 2019 Sep; 120(9):14645-14656. PubMed ID: 31009106
[TBL] [Abstract][Full Text] [Related]
9. Serum long noncoding RNA urothelial carcinoma-associated 1: A novel biomarker for diagnosis and prognosis of hepatocellular carcinoma.
Zheng ZK; Pang C; Yang Y; Duan Q; Zhang J; Liu WC
J Int Med Res; 2018 Jan; 46(1):348-356. PubMed ID: 28856933
[TBL] [Abstract][Full Text] [Related]
10. Serum small extracellular vesicle-derived LINC00853 as a novel diagnostic marker for early hepatocellular carcinoma.
Kim SS; Baek GO; Ahn HR; Sung S; Seo CW; Cho HJ; Nam SW; Cheong JY; Eun JW
Mol Oncol; 2020 Oct; 14(10):2646-2659. PubMed ID: 32525601
[TBL] [Abstract][Full Text] [Related]
11. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection.
Zekri AN; Youssef AS; El-Desouky ED; Ahmed OS; Lotfy MM; Nassar AA; Bahnassey AA
Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989
[TBL] [Abstract][Full Text] [Related]
12. Investigation of long noncoding RNAs expression profile as potential serum biomarkers in patients with hepatocellular carcinoma.
Kamel MM; Matboli M; Sallam M; Montasser IF; Saad AS; El-Tawdi AHF
Transl Res; 2016 Feb; 168():134-145. PubMed ID: 26551349
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic utility of plasma lncRNA small nucleolar RNA host gene 1 in patients with hepatocellular carcinoma.
Gao S; Xu X; Wang Y; Zhang W; Wang X
Mol Med Rep; 2018 Sep; 18(3):3305-3313. PubMed ID: 30066898
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of 5 serum biomarkers for hepatocellular carcinoma with different epidemiological backgrounds: A large-scale, retrospective study.
Liu D; Luo Y; Chen L; Chen L; Zuo D; Li Y; Zhang X; Wu J; Xi Q; Li G; Qi L; Yue X; Zhang X; Sun Z; Zhang N; Song T; Lu W; Guo H
Cancer Biol Med; 2021 Feb; 18(1):256-270. PubMed ID: 33628599
[TBL] [Abstract][Full Text] [Related]
15. Serum LncRNAs Profiles Serve as Novel Potential Biomarkers for the Diagnosis of HBV-Positive Hepatocellular Carcinoma.
Wang K; Guo WX; Li N; Gao CF; Shi J; Tang YF; Shen F; Wu MC; Liu SR; Cheng SQ
PLoS One; 2015; 10(12):e0144934. PubMed ID: 26674525
[TBL] [Abstract][Full Text] [Related]
16. Investigation of serum lncRNA-uc003wbd and lncRNA-AF085935 expression profile in patients with hepatocellular carcinoma and HBV.
Lu J; Xie F; Geng L; Shen W; Sui C; Yang J
Tumour Biol; 2015 May; 36(5):3231-6. PubMed ID: 25501706
[TBL] [Abstract][Full Text] [Related]
17. lncRNA-D16366 Is a Potential Biomarker for Diagnosis and Prognosis of Hepatocellular Carcinoma.
Chao Y; Zhou D
Med Sci Monit; 2019 Sep; 25():6581-6586. PubMed ID: 31475695
[TBL] [Abstract][Full Text] [Related]
18. Association of long noncoding RNA and c-JUN expression in hepatocellular carcinoma.
El-Tawdi AH; Matboli M; El-Nakeep S; Azazy AE; Abdel-Rahman O
Expert Rev Gastroenterol Hepatol; 2016 Jul; 10(7):869-77. PubMed ID: 27215316
[TBL] [Abstract][Full Text] [Related]
19. Identification of long non-coding RNA
Luo P; Liang C; Zhang X; Liu X; Wang Y; Wu M; Feng X; Tu J
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29559565
[TBL] [Abstract][Full Text] [Related]
20. Soluble Axl Is a Novel Diagnostic Biomarker of Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection.
Song X; Wu A; Ding Z; Liang S; Zhang C
Cancer Res Treat; 2020 Jul; 52(3):789-797. PubMed ID: 32138467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
